Abstract:Cornelia de Lange syndrome (CdLS; OMIM: 122470) is characterized by distinctive facial features, growth retardation, hirsutism, and upper limb reduction defects. Craniofacial features manifest as synophrys, arched eyebrows, long thick eyelashes, a small upturned nose, small widely-spaced teeth, and microcephaly. The intelligence quotient (IQ) is usually below the normal level. More phenotypes are frequently found, such as cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia. Some individuals suffering from milder forms of CdLS have less severe growth, cognitive, and limb involvement, but often have typical facial features.1 The prevalence of CdLS is estimated to be 1.6 to 2.2/100 000 live births, without racial variation.2 Most cases are sporadic, and very few familial cases have been reported. Approximately 50%-60% of CdLS cases are caused by mutations in the Nipped-B-like (NIPBL) gene, which encode two isoform products termed delangin-A and delangin-B. Mutations in the Structural Maintenance of Chromosomes 1A (SMC1A) and 3 (SMC3) genes account for ˜5% of CdLS cases and have been shown to cause a consistently mild phenotype.3 All three genes encode components of the sister chromatid cohesin complex. A diagnosis of CdLS is based on not only clinical findings, but also molecular genetic testing. Here, we report the first molecular analysis of a young patient diagnosed with CdLS in China. A 3-year-old girl with multiple congenital anomalies was referred to our clinic. The patient presented typical facial features: arch-like confluent eyebrows, long thick eyelashes, low anterior and posterior hairlines, anteverted nares, collapsed nasal bridge, downturned corners of the mouth, thin lips and low-set ears. She also had microcephaly, small hands with the right missing one digit and the left missing two, hirsutism, and a short neck (Figure 1A and 1B). The girl had developmental delay and mental retardation. She was the first child of her parents who denied a consanguineous relationship, following a first, uneventful pregnancy. There was no positive history of any deformity in the parents' families.Figure 1.: Characteristic features of the CdLS patient and sequencing of the NIPBL gene. A: Arch-like confluent eyebrows, long thick eyelashes, anteverted nares, collapsed nasal bridge, downturned corners of the mouth, thin lips and low-set ears. B: Upper-limb abnormalities. C: Chromographs of the partial cDNA sequence of NIPBL from the patient (upper) and a healthy individual (lower) showing a heterozygous 4-base deletion in exon 44 (c. 7423_7426delGACA) (black arrow).Venous blood samples were obtained from all the family members and 100 unrelated healthy individuals. Genomic DNA was extracted following a standard protocol. The coding exons and flanking intronic sequences of NIPBL (exons 2-47), SMC1A (exons 1-25) and SMC3 (exons 1-29) were amplified by PCR and bidirectional Sanger sequencing. This study was conducted in conformity with the Declaration of Helsinki and approved by Zhejiang University Review Board, and informed consent was given by all participating individuals. Sequencing analysis of the patient revealed a heterozygous, 4-base deletion (c.7423_7426delGACA) in exon 44 of NIPBL, which resulted in a frame-shift, leading to premature termination at codon 2504 (Figure 1C). The variant was not detected in the parents of our patient and the controls, suggesting a de novo event. No mutations in SMC1A or SMC3 were found. NIPBL is located at chromosome 5p13.1. It spans 189 kb of genomic DNA, and is composed of 47 exons. NIPBL is a novel protein displaying homology to Drosophila nipped-B and yeast sister chromatid cohesion protein 2 (scc2).4 The normal NIPBL molecule appears to play a role in sister chromatid cohesion and in regulating long-range enhancer-promoter interactions, possibly through interactions with the cohesin complex.5 To date, more than 80 causative mutations have been reported in patients with CdLS: 20% missense, 40% frame-shift, 20% nonsense, and 15% splice-site mutations (Human Genome Mutation Database: www.hgmd.cf.ac.uk). These mutations may cause loss-of-function alleles, and the severity of phenotypes generally correlates with the type of mutation.3 Analysis of genotype-phenotype associations demonstrated a trend toward a more severe phenotype in patients with nonsense or frame-shift mutations vs. patients with missense mutations or in-frame deletions, especially if the mutations occur in critical domains of the protein.3 In this study, we described the molecular genetic diagnosis of a Chinese girl with classic (severe) CdLS. She carried a heterozygous 4-based deletion (c.7423_7426delGACA) in NIPBL. According to the information available in the Human Genome Mutation Database and to the best of our knowledge, this is a novel de novo mutation of NIPBL that has not been reported elsewhere. The present case is consistent with previous genetic observations in other patients and provides further evidence that more severe symptoms are associated with more severe mutations, especially the frame-shift mutation type, in NIPBL. Because it is a heavy burden for society and families to raise these children, it is appropriate to offer genetic counseling to pedigrees which are affected or at risk. Generally, when the parents of an affected child are apparently clinically unaffected, the risk to the siblings of a child with CdLS has been estimated to be about 1.5% because of the possibility of germline mosaicism. Thus, the determination of genetic risk and discussion of the availability of prenatal testing should be provided before the next pregnancy. Our findings would facilitate family counseling and more definitive predictive prognosis.

Clinical relevance of postzygotic mosaicism in Cornelia de Lange syndrome and purifying selection of NIPBL variants in blood

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

Hidden Mutations in Cornelia de Lange Syndrome Limitations of Sanger Sequencing in Molecular Diagnostics

Disruption of NIPBL/Scc2 in Cornelia de Lange Syndrome provokes cohesin genome-wide redistribution with an impact in the transcriptome

Paternal Gonadal Mosaicism of NIPBL Mutation in a Father of Siblings with Cornelia De Lange Syndrome.

Long-read sequencing reveals chromothripsis in a molecularly unsolved case of Cornelia de Lange syndrome

A Novel de Novo Variant in 5′ UTR of the NIPBL Associated with Cornelia de Lange Syndrome

Case report: Deep sequencing and long-read genome sequencing refine prior genetic analyses in families with apparent gonadal mosaicism in PIK3CD-related activated PI3K delta syndrome

Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data

The NIPBL-gene mutation of a Cornelia de Lange Syndrome patient causes deficits in the hepatocyte differentiation of induced Pluripotent Stem Cells via altered chromatin-accessibility

PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution

A prospective double-blinded non-selection trial of reproductive outcomes and chromosomal normalcy of newborns derived from putative low/moderate-degree mosaic IVF embryos

Two Novel Nipbl Gene Mutations in Chinese Patients with Cornelia De Lange Syndrome

A Novel De Novo Mutation of the Nipped-B-like Gene in an Isolated Chinese Patient with Cornelia De Lange Syndrome.

Cohesin Mutations Induce Chromatin Conformation Perturbation of the H19/ IGF2 Imprinted Region and Gene Expression Dysregulation in Cornelia de Lange Syndrome Cell Lines

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

Assessment of parental mosaicism rates in neurodevelopmental disorders caused by apparent de novo pathogenic variants using deep sequencing

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

Identification of Paternal Germline Mosaicism by MicroSeq and Targeted Next‐generation Sequencing